28
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Call for Papers: Green Renal Replacement Therapy: Caring for the Environment

      Submit here before September 30, 2024

      About Blood Purification: 3.0 Impact Factor I 5.6 CiteScore I 0.83 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Importance of Genetic Diagnostics in Adult-Onset Focal Segmental Glomerulosclerosis

      case-report

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Focal segmental glomerulosclerosis (FSGS) is a histological pattern of podocyte and glomerulus injury. FSGS can be primary and secondary to other diseases or due to a genetic cause. Strikingly, genetic causes for adult-onset FSGS are often overlooked, likely because identifying patients with genetic forms of FSGS based on clinical presentation and histopathology is difficult. Yet diagnosing genetic FSGS does not only have implications for prognostication and therapy but also for family and family planning. In this case series, we present 3 adult patients who presented with advanced renal disease with the histological picture of FSGS and proved to have a genetic cause of the disease, namely, variants in INF2, COL4A4 and HNF1B, respectively. We show the possibilities of identifying genetic FSGS based on clinical clues of a positive family history, early age at onset of disease, and/or severe therapy-resistant disease. We discuss ways to select the method of genetic testing for individual patients. Finally, we examine how the judicious use of genetic investigations can obviate potential harmful diagnostic procedures and direct clinical decisions in patients and their relatives.

          Related collections

          Author and article information

          Journal
          NEF
          Nephron
          10.1159/issn.1660-8151
          Nephron
          S. Karger AG
          1660-8151
          2235-3186
          2019
          July 2019
          16 May 2019
          : 142
          : 4
          : 351-358
          Affiliations
          [_a] aDepartment of Genetics and Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands
          [_b] bDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands
          [_c] cDepartment of Nephrology, University Medical Center Utrecht, Utrecht, The Netherlands
          [_d] dDepartment of Nephrology, Elyse Renal Clinic, Woerden, The Netherlands
          [_e] eDepartment of Nephrology, St. Antonius Hospital, Nieuwegein, The Netherlands
          [_f] fDepartment of Genetics, University Medical Center Groningen, Groningen, The Netherlands
          Author notes
          *Albertien M. van Eerde, MD, PhD, Department of Genetics and Center for Molecular Medicine, University Medical Center Utrecht, Lundlaan 6, NL–3584 EA Utrecht (The Netherlands), E-Mail a.vaneerde@umcutrecht.nl
          Article
          499937 PMC6727320 Nephron 2019;142:351–358
          10.1159/000499937
          PMC6727320
          31096240
          f423a7c9-8b8f-4f17-a26e-3279f5593f7b
          © 2019 The Author(s) Published by S. Karger AG, Basel

          This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 19 October 2018
          : 27 March 2019
          Page count
          Figures: 1, Tables: 2, Pages: 8
          Categories
          Experimental Nephrology and Genetics: Case Study of Genetic Interest

          Cardiovascular Medicine,Nephrology
          Focal segmental glomerulosclerosis,Kidney biopsy,Genetics,Gene panel, INF2 , COL4A4 , HNF1B

          Comments

          Comment on this article